// company-profile

Vistagen Therapeutics, Inc.

VTGN
ExchangeNasdaqSectorPharmaceutical PreparationsInc.NVFilings53Insiders16
// api This Vistagen Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Vistagen Therapeutics, Inc. insiders bought $0 across 9 transactions with no open-market sales.

  • Most active insider: Adler Reid G. with 2 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Vistagen Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$7.9M
QoQ change
-18.1%
Reporting period
2026-03-31
#1
ORBIMED ADVISORS LLC
CIK 1055951
$1.7M
3.1M shares
#2
TCG Crossover Management, LLC
CIK 1839948
$1.5M
2.7M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$900,442
1.6M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
May 18, 2026Angelov Angel SVTGN
Award
150,000
Apr 7, 2026Adler Reid G.VTGN
Award
56,247$0.00$0K
Apr 7, 2026Cote Elissa S.VTGN
Award
75,000$0.00$0K
Apr 7, 2026Adler Reid G.VTGN
Award
18,753$0.00$0K
Apr 7, 2026Prince Joshua S.VTGN
Award
18,752$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.